Enveric Biosciences Inc vs Fabrinet — how do they compare? Enveric Biosciences Inc trades at $1.43 (market cap $5.32M), while Fabrinet trades at $465.29 (market cap $17.44B). The key difference: Fabrinet is far larger — about 3278.2× Enveric Biosciences Inc's market cap, and Fabrinet is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | FN | |
|---|---|---|
Market Cap | $5.32M | $17.44B |
Sector | Health | Technology |
52-Week High | $17.40 | $746.47 |
52-Week Low | $1.28 | $277.04 |
Enterprise Value | $408.82K | $16.50B |
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →